Table 2

Summary of results for primary outcomes related to study feasibility

VariableAll
n=46		Patients, by sitePatients, by treatment group
Primary
n=30		Partner
n=16		PMoveTrain
n=23		Standard
n=23		P
Retention rate, n (%)*42 (91)30 (100)12 (75)0.01†22 (96)20 (87)0.61†
Patient adherent to treatment session attendance, n (%)‡43 (93)30 (100)13 (81)0.04†21 (91)22 (96)1.0†
All
n=43§		Primary
n=30§		Partner
n=13§		PMoveTrain
n=21§		Standard
n=22§		P
HEP adherence, median % (range)¶62
(9–97)		62
(18–95)		63
(9–97)		0.50**61
(18–85)		75
(9–97)		0.22**
Patient treatment receipt, median %
(range)††		91
(18–100)		92
(68–100)		83
(18–98)		0.47**88
(18–100)		93
(81–100)		0.05**
All
n=45‡‡		Primary
n=30‡‡		Partner
n=15‡‡		PMoveTrain
n=30‡‡		Standard
n=15‡‡		P
Active ingredients for treatment delivery, median % (range)§§90
(60–100)		90
(60–100)		92
(73–100)		<0.01**90
(60–100)		90
(67–100)		0.83**

  • *Retention rate is defined as the percentage of those enrolled at baseline who completed testing after treatment.

  • †Fisher’s exact test for group comparison.

  • ‡Treatment session attendance was documented by the physical therapist. The variable for treatment session attendance is the number of patients who attended at least 90% (9 of 10) of their sessions.

  • §Number of patients completing at least nine supervised visits.

  • ¶HEP adherence: participants were instructed to perform their HEP one time per day. The variable for HEP adherence was calculated as the total number of days reported by the participant to have completed the prescribed exercises, summed over the entire treatment period and divided by the total number of treatment days.

  • **Wilcoxon’s test.

  • ††The total number of exercises the physical therapist reviewed and the total number of those exercises they rated as independent were each summed across all treatment visits to derive the per cent of exercises rated as independent across the entire treatment (Σ independent / Σ reviewed * 100).

  • ‡‡Number of patients who completed at least one supervised treatment visit.

  • §§Treatment delivery assessed using chart reviews to determine if the active ingredients of the treatment was provided. The variable for treatment delivery is the proportion of active ingredients completed and documented by the treatment physical therapists for 132 treatment visits.

  • HEP, home exercise programme; MoveTrain, movement pattern training group.